Renovaro biosciences welcomes gedicube announcement of new joint effort

Los angeles, aug. 30, 2023 (globe newswire) -- (nasdaq: renb). renovaro biosciences congratulates gedicube on their joint effort to work to accelerate early diagnosis of cancer in clinical trials.
RENB Ratings Summary
RENB Quant Ranking